Work

P2 study of ADXS11-001 Immunotherapy in patients with persistent/recurrent, surgically unresectable locoregional, or metastatic squamous cell anal cancer

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx393.063

Authors: C. Eng, M. Fakih, M. Amin, V. Morris, H.S. Hochster, P.M. Boland, H. Uronis

Institutions: The University of Texas MD Anderson Cancer Center, City Of Hope National Medical Center, City of Hope, Washington University in St. Louis, Yale Cancer Center, Yale University, Roswell Park Comprehensive Cancer Center, Duke Cancer Institute

Language: English

Topic: Colorectal and Anal Carcinomas

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2761414259

FWCI: 1.015

Cites:

Cited by: 5

Related to: 10